Medical network - on March 2, in recent years, as the population ages, the antipyretic analgesic products market demand increased year by year. In 2015 the overall scale of China's antipyretic analgesics is 13.8 billion yuan, up 5.5% from 2014. Among them, the internal and antipyretic analgesic dosage the biggest, for 68.3% of the total in 2015.
Antipyretic analgesic drugs is an international pharmaceutical sales great bulk drugs on the market, the year sales volume total up to more than 20, ten thousand tons. As the world many countries entered the aging society, and the elderly more pain, so the antipyretic analgesic products market demand is growing year by year. In addition to the type of oral analgesic agents, over the past few years in the international market for the treatment of osteoarthritis pain, walk movement caused by muscle soreness and neuropathic pain syndrome type of topical preparations is also sales surge, have become the fresh power to promote the rapid growth of global antipyretic analgesic drug market momentum.
13.8 billion the size of the market, a steady growth trend
According to kang CMH monitoring data show that in 2015 the overall scale of China's antipyretic analgesics (according to the five terminal price calculation, similarly hereinafter) is 13.8 billion yuan, up 5.5% from 2014. Is predicted to grow 8.0% in 2016, the overall size of the market, the scale will reach 14.9 billion yuan.
Figure 1 2014-2016 - e antipyretic analgesics market size (unit: one hundred million yuan)
Data sources: kang CMH
The internal treatment as the main method
Antipyretic analgesic, cavity/applied to take orally, skin mucous membrane to drug delivery system and injection of the big four, among them, the internal treatment is antipyretic analgesic dosage the biggest, the proportion of 68.3% in 2015.
Figure 2 dosage antipyretic analgesic drugs in 2015 accounted for
City level hospital market is active
From five terminals, city level hospital and retail pharmacy is the main use of antipyretic analgesics channels, sales contribution amount to 74.9% in 2015. Among them, the city level hospital sales contribution in 2015 was 45.4%, in 2016 is expected to further improve.
In figure 3, 2014-2016 - e antipyretic analgesic medicinal drug channel sales accounted for
Data sources: kang CMH
Domestic enterprises to dominate the market
From five terminals, antipyretic analgesic market mainly by domestic enterprises, domestic enterprises in 2015 in the city basic-level hospital sales accounted for 95.6%, maximum is higher than the other four sales terminal. The foreign capital enterprise at the county level hospital sales the best, sales 53.1% in 2015.
Figure 4 systemic allergic medicinal drugs in 2014-2015 five terminal market sales proportion of domestic and foreign enterprises
Data sources: kang CMH
Top ten enterprise scale
According to kang CMH monitoring data show that in 2015, antipyretic analgesic five terminal market totaled 43.3% share of the top ten enterprises, market concentration is higher. From TOP5 ranking of domestic and foreign enterprises, foreign capital enterprise's overall ranking situation slightly better than domestic enterprises, Pfizer for two consecutive years ranked first, the market share of more than 11%.
Table 1 2015-2016 - e antipyretic analgesics five top 10 enterprises terminal sales accounted for
The top ten brand analysis
In the top ten brand competition, flurbiprofen acetate injection ted pharmaceutical (Beijing) 2015 market share of 8.2%, ranking first, market share will rise to 9.3% in 2016, is expected to further widens the gap between with other brands.
Table 2 2015-2016 - e antipyretic analgesics top 10 brands share sales
|
